Informed commercial potential of an asset help companies in guiding the investment, efforts and understanding potential return on investment.

MedDx helps companies in commercial assessment of their asset by estimating the market size, forecasting and valuation of an asset to aid in apt, effective and commercially beneficial decision making process.

Depending on the therapy area and product type, we use bottom-up, top-down and dynamic disease models which is supported by extensive understating of the domain and appropriate assumptions.